-
1
-
-
0027256664
-
Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
-
Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N, (1993) Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268: 10425-10432.
-
(1993)
J Biol Chem
, vol.268
, pp. 10425-10432
-
-
Kjeldsen, L.1
Johnsen, A.H.2
Sengelov, H.3
Borregaard, N.4
-
2
-
-
0029790266
-
The lipocalin protein family: structure and function
-
Flower DR, (1996) The lipocalin protein family: structure and function. Biochem J 318 (Pt 1):: 1-14.
-
(1996)
Biochem J
, vol.318
, Issue.Pt 1
, pp. 1-14
-
-
Flower, D.R.1
-
3
-
-
0034684231
-
Lipocalins and cancer
-
Bratt T, (2000) Lipocalins and cancer. Biochim Biophys Acta 1482: 318-326.
-
(2000)
Biochim Biophys Acta
, vol.1482
, pp. 318-326
-
-
Bratt, T.1
-
4
-
-
14844331424
-
Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro
-
Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, et al. (2005) Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280: 7875-7882.
-
(2005)
J Biol Chem
, vol.280
, pp. 7875-7882
-
-
Gwira, J.A.1
Wei, F.2
Ishibe, S.3
Ueland, J.M.4
Barasch, J.5
-
5
-
-
41149144686
-
Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer
-
Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, et al. (2008) Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 108: 389-397.
-
(2008)
Breast Cancer Res Treat
, vol.108
, pp. 389-397
-
-
Bauer, M.1
Eickhoff, J.C.2
Gould, M.N.3
Mundhenke, C.4
Maass, N.5
-
6
-
-
0029563573
-
Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas
-
Stoesz SP, Gould MN, (1995) Overexpression of neu-related lipocalin (NRL) in neu-initiated but not ras or chemically initiated rat mammary carcinomas. Oncogene 11: 2233-2241.
-
(1995)
Oncogene
, vol.11
, pp. 2233-2241
-
-
Stoesz, S.P.1
Gould, M.N.2
-
7
-
-
34547747873
-
Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer
-
Kubben FJ, Sier CF, Hawinkels LJ, Tschesche H, van Duijn W, et al. (2007) Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer. Eur J Cancer 43: 1869-1876.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1869-1876
-
-
Kubben, F.J.1
Sier, C.F.2
Hawinkels, L.J.3
Tschesche, H.4
van Duijn, W.5
-
8
-
-
78049486436
-
Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test
-
Wang HJ, He XJ, Ma YY, Jiang XT, Xia YJ, et al. (2010) Expressions of neutrophil gelatinase-associated lipocalin in gastric cancer: a potential biomarker for prognosis and an ancillary diagnostic test. Anat Rec (Hoboken) 293: 1855-1863.
-
(2010)
Anat Rec (Hoboken)
, vol.293
, pp. 1855-1863
-
-
Wang, H.J.1
He, X.J.2
Ma, Y.Y.3
Jiang, X.T.4
Xia, Y.J.5
-
9
-
-
34249914771
-
Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion
-
Zhang H, Xu L, Xiao D, Xie J, Zeng H, et al. (2007) Upregulation of neutrophil gelatinase-associated lipocalin in oesophageal squamous cell carcinoma: significant correlation with cell differentiation and tumour invasion. J Clin Pathol 60: 555-561.
-
(2007)
J Clin Pathol
, vol.60
, pp. 555-561
-
-
Zhang, H.1
Xu, L.2
Xiao, D.3
Xie, J.4
Zeng, H.5
-
10
-
-
77954365854
-
Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade
-
Barresi V, Ieni A, Bolignano D, Magno C, Buemi M, et al. (2010) Neutrophil gelatinase-associated lipocalin immunoexpression in renal tumors: correlation with histotype and histological grade. Oncol Rep 24: 305-310.
-
(2010)
Oncol Rep
, vol.24
, pp. 305-310
-
-
Barresi, V.1
Ieni, A.2
Bolignano, D.3
Magno, C.4
Buemi, M.5
-
11
-
-
52949106096
-
The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells
-
Iannetti A, Pacifico F, Acquaviva R, Lavorgna A, Crescenzi E, et al. (2008) The neutrophil gelatinase-associated lipocalin (NGAL), a NF-kappaB-regulated gene, is a survival factor for thyroid neoplastic cells. Proc Natl Acad Sci U S A 105: 14058-14063.
-
(2008)
Proc Natl Acad Sci U S A
, vol.105
, pp. 14058-14063
-
-
Iannetti, A.1
Pacifico, F.2
Acquaviva, R.3
Lavorgna, A.4
Crescenzi, E.5
-
12
-
-
34247359877
-
Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition
-
Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, et al. (2007) Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 120: 2426-2434.
-
(2007)
Int J Cancer
, vol.120
, pp. 2426-2434
-
-
Lim, R.1
Ahmed, N.2
Borregaard, N.3
Riley, C.4
Wafai, R.5
-
13
-
-
27444447914
-
Neutrophil gelatinase-associated lipocalin as a survival factor
-
Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, et al. (2005) Neutrophil gelatinase-associated lipocalin as a survival factor. Biochem J 391: 441-448.
-
(2005)
Biochem J
, vol.391
, pp. 441-448
-
-
Tong, Z.1
Wu, X.2
Ovcharenko, D.3
Zhu, J.4
Chen, C.S.5
-
14
-
-
33646436461
-
Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells
-
Lee HJ, Lee EK, Lee KJ, Hong SW, Yoon Y, et al. (2006) Ectopic expression of neutrophil gelatinase-associated lipocalin suppresses the invasion and liver metastasis of colon cancer cells. Int J Cancer 118: 2490-2497.
-
(2006)
Int J Cancer
, vol.118
, pp. 2490-2497
-
-
Lee, H.J.1
Lee, E.K.2
Lee, K.J.3
Hong, S.W.4
Yoon, Y.5
-
15
-
-
80051790728
-
Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma?
-
Barresi V, Di Gregorio C, Reggiani-Bonetti L, Ieni A, Ponz-De Leon M, et al. (2011) Neutrophil gelatinase-associated lipocalin: a new prognostic marker in stage I colorectal carcinoma? Hum Pathol 42: 1720-1726.
-
(2011)
Hum Pathol
, vol.42
, pp. 1720-1726
-
-
Barresi, V.1
Di Gregorio, C.2
Reggiani-Bonetti, L.3
Ieni, A.4
Ponz-De Leon, M.5
-
16
-
-
79960314350
-
NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models
-
Sun Y, Yokoi K, Li H, Gao J, Hu L, et al. (2011) NGAL expression is elevated in both colorectal adenoma-carcinoma sequence and cancer progression and enhances tumorigenesis in xenograft mouse models. Clin Cancer Res 17: 4331-4340.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 4331-4340
-
-
Sun, Y.1
Yokoi, K.2
Li, H.3
Gao, J.4
Hu, L.5
-
17
-
-
0031738123
-
Heterogeneous expression of the lipocalin NGAL in primary breast cancers
-
Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, et al. (1998) Heterogeneous expression of the lipocalin NGAL in primary breast cancers. Int J Cancer 79: 565-572.
-
(1998)
Int J Cancer
, vol.79
, pp. 565-572
-
-
Stoesz, S.P.1
Friedl, A.2
Haag, J.D.3
Lindstrom, M.J.4
Clark, G.M.5
-
19
-
-
13244268450
-
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study
-
Bonadonna G, Moliterni A, Zambetti M, Daidone MG, Pilotti S, et al. (2005) 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study. BMJ 330: 217.
-
(2005)
BMJ
, vol.330
, pp. 217
-
-
Bonadonna, G.1
Moliterni, A.2
Zambetti, M.3
Daidone, M.G.4
Pilotti, S.5
-
20
-
-
0035751675
-
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
-
Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B, (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr pp. 96-102.
-
(2001)
J Natl Cancer Inst Monogr
, pp. 96-102
-
-
Wolmark, N.1
Wang, J.2
Mamounas, E.3
Bryant, J.4
Fisher, B.5
-
21
-
-
33749061057
-
Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response
-
Jones RL, Smith IE, (2006) Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 7: 869-874.
-
(2006)
Lancet Oncol
, vol.7
, pp. 869-874
-
-
Jones, R.L.1
Smith, I.E.2
-
22
-
-
0031926839
-
Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
-
Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, et al. (1998) Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 16: 2672-2685.
-
(1998)
J Clin Oncol
, vol.16
, pp. 2672-2685
-
-
Fisher, B.1
Bryant, J.2
Wolmark, N.3
Mamounas, E.4
Brown, A.5
-
23
-
-
33646445341
-
Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27
-
Bear HD, Anderson S, Smith RE, Geyer CE Jr, Mamounas EP, et al. (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 24: 2019-2027.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2019-2027
-
-
Bear, H.D.1
Anderson, S.2
Smith, R.E.3
Geyer Jr., C.E.4
Mamounas, E.P.5
-
24
-
-
33947207819
-
HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination
-
Tiezzi DG, Andrade JM, Ribeiro-Silva A, Zola FE, Marana HR, et al. (2007) HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination. BMC Cancer 7: 36.
-
(2007)
BMC Cancer
, vol.7
, pp. 36
-
-
Tiezzi, D.G.1
Andrade, J.M.2
Ribeiro-Silva, A.3
Zola, F.E.4
Marana, H.R.5
-
25
-
-
33745609547
-
Primary systemic therapy in operable breast cancer: clinical data and biological fall-out
-
Maur M, Guarneri V, Frassoldati A, Conte PF, (2006) Primary systemic therapy in operable breast cancer: clinical data and biological fall-out. Ann Oncol 17 Suppl 5: v158-164.
-
(2006)
Ann Oncol
, vol.17
, Issue.SUPPL. 5
-
-
Maur, M.1
Guarneri, V.2
Frassoldati, A.3
Conte, P.F.4
-
26
-
-
33646885250
-
Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer
-
Fernandez-Sanchez M, Gamboa-Dominguez A, Uribe N, Garcia-Ulloa AC, Flores-Estrada D, et al. (2006) Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer. Med Oncol 23: 171-183.
-
(2006)
Med Oncol
, vol.23
, pp. 171-183
-
-
Fernandez-Sanchez, M.1
Gamboa-Dominguez, A.2
Uribe, N.3
Garcia-Ulloa, A.C.4
Flores-Estrada, D.5
-
27
-
-
1642473193
-
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
-
Mathieu MC, Rouzier R, Llombart-Cussac A, Sideris L, Koscielny S, et al. (2004) The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile. Eur J Cancer 40: 342-351.
-
(2004)
Eur J Cancer
, vol.40
, pp. 342-351
-
-
Mathieu, M.C.1
Rouzier, R.2
Llombart-Cussac, A.3
Sideris, L.4
Koscielny, S.5
-
28
-
-
23844549918
-
Breast cancer molecular subtypes respond differently to preoperative chemotherapy
-
Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, et al. (2005) Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 11: 5678-5685.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5678-5685
-
-
Rouzier, R.1
Perou, C.M.2
Symmans, W.F.3
Ibrahim, N.4
Cristofanilli, M.5
-
29
-
-
28044472321
-
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer
-
Gianni L, Zambetti M, Clark K, Baker J, Cronin M, et al. (2005) Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. J Clin Oncol 23: 7265-7277.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7265-7277
-
-
Gianni, L.1
Zambetti, M.2
Clark, K.3
Baker, J.4
Cronin, M.5
-
30
-
-
33646339959
-
Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer
-
Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, et al. (2006) Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer. J Clin Oncol 24: 1839-1845.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1839-1845
-
-
Thuerigen, O.1
Schneeweiss, A.2
Toedt, G.3
Warnat, P.4
Hahn, M.5
-
31
-
-
33749030177
-
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
-
Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, et al. (2006) Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24: 4236-4244.
-
(2006)
J Clin Oncol
, vol.24
, pp. 4236-4244
-
-
Hess, K.R.1
Anderson, K.2
Symmans, W.F.3
Valero, V.4
Ibrahim, N.5
-
32
-
-
43149114454
-
Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study
-
von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, et al. (2008) Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. J Natl Cancer Inst 100: 552-562.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 552-562
-
-
von Minckwitz, G.1
Kummel, S.2
Vogel, P.3
Hanusch, C.4
Eidtmann, H.5
-
33
-
-
43149120682
-
Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial
-
von Minckwitz G, Kummel S, Vogel P, Hanusch C, Eidtmann H, et al. (2008) Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Cancer Inst 100: 542-551.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 542-551
-
-
von Minckwitz, G.1
Kummel, S.2
Vogel, P.3
Hanusch, C.4
Eidtmann, H.5
-
34
-
-
77957710541
-
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
-
Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, et al. (2010) Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study. Breast Cancer Res Treat 124: 133-140.
-
(2010)
Breast Cancer Res Treat
, vol.124
, pp. 133-140
-
-
Huober, J.1
von Minckwitz, G.2
Denkert, C.3
Tesch, H.4
Weiss, E.5
-
35
-
-
0032896905
-
Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer
-
Harvey JM, Clark GM, Osborne CK, Allred DC, (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17: 1474-1481.
-
(1999)
J Clin Oncol
, vol.17
, pp. 1474-1481
-
-
Harvey, J.M.1
Clark, G.M.2
Osborne, C.K.3
Allred, D.C.4
-
36
-
-
0032799411
-
Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression
-
Friedl A, Stoesz SP, Buckley P, Gould MN, (1999) Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 31: 433-441.
-
(1999)
Histochem J
, vol.31
, pp. 433-441
-
-
Friedl, A.1
Stoesz, S.P.2
Buckley, P.3
Gould, M.N.4
-
37
-
-
13844310310
-
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
-
Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679.
-
(2005)
Lancet
, vol.365
, pp. 671-679
-
-
Wang, Y.1
Klijn, J.G.2
Zhang, Y.3
Sieuwerts, A.M.4
Look, M.P.5
-
38
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347: 1999-2009.
-
(2002)
N Engl J Med
, vol.347
, pp. 1999-2009
-
-
van de Vijver, M.J.1
He, Y.D.2
van't Veer, L.J.3
Dai, H.4
Hart, A.A.5
-
39
-
-
53049100145
-
Predictive markers of response to neoadjuvant chemotherapy in breast cancer
-
Tewari M, Krishnamurthy A, Shukla HS, (2008) Predictive markers of response to neoadjuvant chemotherapy in breast cancer. Surg Oncol 17: 301-311.
-
(2008)
Surg Oncol
, vol.17
, pp. 301-311
-
-
Tewari, M.1
Krishnamurthy, A.2
Shukla, H.S.3
-
40
-
-
79957940705
-
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy
-
von Minckwitz G, Muller BM, Loibl S, Budczies J, Hanusch C, et al. (2011) Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol 29: 2150-2157.
-
(2011)
J Clin Oncol
, vol.29
, pp. 2150-2157
-
-
von Minckwitz, G.1
Muller, B.M.2
Loibl, S.3
Budczies, J.4
Hanusch, C.5
-
41
-
-
67650349829
-
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer
-
Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, et al. (2009) Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer. Breast Cancer Res 11: 205.
-
(2009)
Breast Cancer Res
, vol.11
, pp. 205
-
-
Oakman, C.1
Bessi, S.2
Zafarana, E.3
Galardi, F.4
Biganzoli, L.5
-
42
-
-
73649135741
-
Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene
-
Bolignano D, Donato V, Lacquaniti A, Fazio MR, Bono C, et al. (2010) Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene. Cancer Lett 288: 10-16.
-
(2010)
Cancer Lett
, vol.288
, pp. 10-16
-
-
Bolignano, D.1
Donato, V.2
Lacquaniti, A.3
Fazio, M.R.4
Bono, C.5
-
43
-
-
23044499535
-
The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients
-
Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, et al. (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11: 5390-5395.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5390-5395
-
-
Fernandez, C.A.1
Yan, L.2
Louis, G.3
Yang, J.4
Kutok, J.L.5
|